NeuroVive has purchased a set of cyclophilin inhibitors, technology platform assets and associated intellectual property rights from Biotica to widen its mitochondrial medicine pipeline. The acquired portfolio of cyclophilin inhibitors ...
Tags: NeuroVive, mitochondrial medicine pipeline, cyclophilin inhibitors